Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Lifestyle Factors and Health

Lifestyle Factors and Health

Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sex Differences in Pediatric and Adolescent Endocrinology: What Are the Origins?

Hormone research in paediatrics·2026

Same author

Trends in pharmacological management of paediatric patients with type 2 diabetes from 2000 to 2023 in German-speaking countries: Analysis based on the Diabetes Prospective Follow-up Registry.

Diabetes, obesity & metabolism·2024

Same author

Youths with Extreme Obesity: A High-Risk Group for Pain and Mental Health Impairments.

Obesity facts·2024

Same author

Global Adrenal Insufficiency in Two Independent Patients Carrying the Same Homozygous c.172A>G, p.(Thr58Ala) Mutation in the <italic>TBX19</italic> Gene.

Hormone research in paediatrics·2024

Same author

New liquid chromatography tandem mass spectrometry reference data for estradiol show mini-puberty in both sexes and typical pre-pubertal and pubertal patterns.

European journal of endocrinology·2024

Same author

Clinical characteristics and outcomes of children, adolescents and young adults with overweight or obesity and mental health disorders.

International journal of obesity (2005)·2024

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence.

Thomas Reinehr¹, Michaela Kleber, Andre Michael Toschke

¹Vestische Hospital for Children and Adolescents, University of Witten/Herdecke, Germany. T.Reinehr@kinderklinik-datteln.de

Atherosclerosis

|May 16, 2009

Summary

Lifestyle intervention effectively reduces obesity and metabolic syndrome in children. Greater weight loss significantly improves metabolic syndrome components, highlighting the intervention

More Related Videos

Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil

Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil

Published on: July 29, 2020

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Jun 23, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil

Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil

Published on: July 29, 2020

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

Area of Science:

Pediatrics
Metabolic Health
Obesity Management

Background:

Obesity in children presents significant health risks.
Weight loss is crucial for mitigating obesity-related health issues.
Limited research exists on lifestyle interventions' impact on metabolic syndrome in obese children.

Purpose of the Study:

To evaluate the effectiveness of a 1-year outpatient lifestyle intervention on weight status and metabolic syndrome in obese children.
To compare outcomes in children receiving lifestyle intervention versus a control group.

Main Methods:

Analysis of weight status, 2-hour glucose levels (oral glucose tolerance tests), fasting glucose, lipids, blood pressure, and metabolic syndrome prevalence.
Comparison between 288 obese children undergoing a 1-year lifestyle intervention and 186 obese children without intervention.
Ensured comparability between groups based on age, gender, and weight status distributions.

Main Results:

Lifestyle intervention significantly decreased SDS-BMI (mean -0.22), while it increased in the control group (mean +0.15).
Metabolic syndrome prevalence reduced from 19% to 9% in the intervention group, with improvements in waist circumference, blood pressure, and 2-hour glucose.
The degree of weight loss correlated positively with improvements in metabolic syndrome components; a SDS-BMI reduction >0.5 improved all components.

Conclusions:

Lifestyle intervention is effective in promoting weight loss and improving metabolic syndrome and its components in obese children.
The extent of weight loss achieved through lifestyle intervention is directly associated with the degree of improvement in metabolic syndrome prevalence and its individual factors.